Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies
Indian biotech start-up Immuneel Therapeutics has announced it has started patient dosing in a CAR-T trial named “IMAGINE.”
Synthetic CAR Libraries May Aid Immunotherapy Development
Over the past decade, substantial progress has been made in modern immunotherapy, driven by targeted therapies that inhibit tumor angiogenesis and intrinsic drivers of cancer-cell growth.
